Manulife Financial Corporation

Q2 FY26Insurance

Manulife Financial Corporation Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹38

Market cap₹63.9K Cr

P/E15.3

Published29 May 2026

What the Q2 FY26 call signalled

3 of 4 strong

RevenueRank 3

MarginRank 2

CapexYes

Order bookYes

Not discussed on this call: fundraise.

The short version

- GWAM business expects margin expansion and positive operating leverage going forward, with a target EBITDA margin of 30% next year, implying solid revenue growth alongside controlled expenses (Paul Lorentz, Page 13). - GWAM gross flows hit a record $56 billion, up 13% from prior quarter and 15% year-on-year; AI investments improving wholesaling productivity and expanding teams globally to support top-line growth (Page 10). - Asia region shows strong momentum with double-digit growth in APE sales in Hong Kong, Japan, Singapore; Asia core earnings up 22% YoY (Page 3, 11, 13). - U.S. - Global WAM: Expect margin expansion and positive operating leverage going forward, targeting a 30% EBITDA margin next year, driven by controlled expense growth (50% of revenue) and investments in AI and efficiency.

From Manulife Financial Corporation's Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Rank 3

GWAM business expects margin expansion and positive operating leverage going forward, with a target EBITDA margin of 30% next year, implying solid revenue growth alongside controlled expenses (Paul Lorentz, Page 13).
GWAM gross flows hit a record $56 billion, up 13% from prior quarter and 15% year-on-year; AI investments improving wholesaling productivity and expanding teams globally to support top-line growth (Page 10).
Asia region shows strong momentum with double-digit growth in APE sales in Hong Kong, Japan, Singapore; Asia core earnings up 22% YoY (Page 3, 11, 13).
U.S. insurance segment sales grew 29% YoY, driven by accumulation products and expanded wholesaling force; optimism on future growth due to differentiated product offerings like Vitality (Page 9, 7).
Canada individual insurance sales growing strongly despite lumpiness in group sales; positive outlook on insurance product demand supported by favorable interest rate environment (Page 15, 5).
Overall, cautious optimism on flows and revenues with plans to return to positive net flows in GWAM over time amid market uncertainties (Page 10).

Profitability & Margins

Global WAM: Expect margin expansion and positive operating leverage going forward, targeting a 30% EBITDA margin next year, driven by controlled expense growth (50% of revenue) and investments in AI and efficiency. (Pages 13-14)
U.S. Business: Earnings expected to shift from net investment income to core insurance results due to product mix changes; baseline earnings run rate around USD 230-240 million. (Pages 8-9)
Asia: Continued strong business growth, with sustainable earnings levels supported by product and distribution expansion. (Page 4)
Canada: Core earnings decline due to unfavorable insurance experience, but underlying individual insurance growth supports new business CSM increase. (Page 3-4)
Overall: Core EPS up 11% YoY; adjusted book value per share up 6%. Expect improvements towards Investor Day targets (18% operating ROE by 2027). (Pages 3, 13-14)

See what Manulife Financial Corporation said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Significant investments in AI and technology initiatives across the enterprise:
- Collaborations with AKKA and Adaptive ML to scale AI deployment efficiently.
- AI-powered sales platform in U.S. retail driving a 40% increase in meaningful adviser interactions, supporting higher flows.
- AI tools rollout across Asia to boost agent and adviser productivity (new distributor AI tool in Vietnam, adviser AI enhancements in Japan).
- Expansion of the U.S. Quick Quote support tool, automating nearly half of preliminary assessments and drastically reducing turnaround time.
Expansion of the U.S. wholesaling team by more than 50% over the past year to deepen adviser relationships and support new product launches.
Recent acquisition of Schroders Indonesia to strengthen position as the largest asset manager in Indonesia.
Strategic partnership with L&G to expand global asset management and distribution capabilities.
Partnership with Guardant Health in Asia for early cancer detection tests.
Partnership with Osara Health in Canada for cancer support programs.

Fundraising & Capital Structure

No explicit mention of new fundraising through debt or equity in the provided pages.
The company emphasizes strong capital generation and remittances, exceeding previous targets.
Capital position is strong with LICAT ratio at 136%, well above supervisory target, and financial leverage at 22.5%, below medium-term target of 25%.
Preference is indicated for organic growth and disciplined capital deployment.
Although recent M&A activity mentioned (e.g., acquisitions of CQS, Comvest), the primary focus remains organic execution with a high bar for inorganic deployment.
No stated plans for immediate equity or debt issuance; capital returned to shareholders via dividends and share buybacks.

See what Manulife Financial Corporation said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Yes

The provided pages from the document do not contain specific information about current or expected orderbook or pending orders. The discussion primarily focuses on financial performance, business segments, earnings outlook, investment flows, and strategic priorities across various regions and business units. Key highlights include: - Strong momentum in GWAM with record gross flows of $56 billion in Q1. - Positive outlook on net flows with expectations of improvement over time despite industry pressures. - Increased investment in AI to boost distribution productivity. - Robust sales in the U.S. insurance business with product innovation and expanded wholesaling teams. - No direct mention of orderbook or pending orders figures. If you need detailed orderbook or pending orders data, please provide specific sections or documents containing that information.

How does Manulife Financial Corporation rank vs peers in Insurance?

Pro feature

ThisManulife Financial Corporation

Rev 3Mar 2

See where Manulife Financial Corporation sits in InsuranceSee which companies these are, and every other name in the sector.Open rankings

Others in Insurance this season

American Financial Group, Inc. (Q2 FY26)
American Financial Group, Inc. Q2 FY26 quarterly results analysis. Crop insurance gross written premium expected to be flat; net written premiums projected to i
Erie Indemnity Company (Q2 FY26)
Erie Indemnity Company Q2 FY26 quarterly results analysis. Erie expects continued rollout and expansion of Erie Secure Auto into additional states this year, fo
CNA Financial Corporation (Q2 FY26)
CNA Financial Corporation Q2 FY26 quarterly results analysis. Net written premium growth was 1% in Q1 2026, with significant variation by segment and class. Mar
RenaissanceRe Holdings Ltd. (Q2 FY26)
RenaissanceRe Holdings Ltd. Q2 FY26 quarterly results analysis. New demand at midyear renewals is increasing, now estimated closer to $15 billion for U.S. Marke

Compare:vs The Progressive Corporation vs Marsh & McLennan Companies, Inc.vs Aon plc

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Manulife Financial Corporation Q2 FY26 results?

What is Manulife Financial Corporation share price analysis?

Manulife Financial Corporation currently shows a below-average growth signal. The stock trades at a P/E of 15.3 with a market cap of $63,902. Investors should review the full earnings analysis for detailed insights.

Is Manulife Financial Corporation planning capital expenditure?

- Significant investments in AI and technology initiatives across the enterprise: - Collaborations with AKKA and Adaptive ML to scale AI deployment efficiently. - AI-powered sales platform in U.S.

Keep Manulife Financial Corporation on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.